Sign Up
OverviewAPI
The global oncology drugs market is poised to reach $474.06 billion by 2030, growing at a steady rate driven by factors like increasing cancer cases and R&D investments. Market segmentation includes therapy type, drug class, and distribution channels, with targeted therapy and injectables leading the way. Major players such as AbbVie, Takeda Pharmaceutical, and Roche are actively engaged in mergers and acquisitions.

Ask a question